IPN10200 placebo, DYSPORT 300 UNITES SPEYWOOD, poudre pour solution injectable, IPN10200
D-FR-10200-002
Phase 2 small_molecule active
Quick answer
IPN10200 placebo, DYSPORT 300 UNITES SPEYWOOD, poudre pour solution injectable, IPN10200 for Treatment of Moderate to Severe Upper Facial Lines is a Phase 2 program (small_molecule) at Ipsen Pharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ipsen Pharma
- Indication
- Treatment of Moderate to Severe Upper Facial Lines
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active